Robert W. Mcmahon
Director; SVP & Chief Financial Officer · 5 filings · Latest: Aug 11, 2026
ORASURE TECHNOLOGIES INC
WEST PHARMACEUTICAL SERVICES INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
WST | Robert W. Mcmahon | SVP & Chief Financial Officer | Aug 11, 2026 | Option Exercise | — | 7,149.205 | — | 9,784.181 | |
WST | Robert W. Mcmahon | SVP & Chief Financial Officer | Feb 11, 2026 | Option Exercise | — | 4,230.525 | — | 4,230.525 | |
A | McMahon Robert W. | — | Sep 9, 2025 | Proposed Sale | $126.21 | 5,781 | $729.6K | — | |
A | McMahon Robert W. | — | Sep 4, 2025 | Proposed Sale | $128.62 | 15,303 | $2.0M | — | |
A | McMahon Robert W. | — | Aug 29, 2025 | Proposed Sale | $124.96 | 28,081 | $3.5M | — |